Related references
Note: Only part of the references are listed.Skeletal Health: Primate Model of Postmenopausal Osteoporosis
S. Y. Smith et al.
AMERICAN JOURNAL OF PRIMATOLOGY (2009)
A Short Treatment With an Antibody to Sclerostin Can Inhibit Bone Loss in an Ongoing Model of Colitis
Alison Eddleston et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Potential new drug targets for osteoporosis
Chad Deal
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2009)
Wnt signaling: A win for bone
Elke Piters et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Minireview:: Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton
Roland Baron et al.
ENDOCRINOLOGY (2007)
Update in osteoporosis and metabolic bone disorders
Dolores Shoback
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine
John Fox et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis
Yanfei L. Ma et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: Early actions of teriparatide
R Lindsay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
The natural history of sclerosteosis
H Hamersma et al.
CLINICAL GENETICS (2003)
Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis
AB Hodsman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Nonhuman primate models in skeletal research
CP Jerome et al.
BONE (2001)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
